Basic Isordil Information

• INN (International Nonproprietary Name): Isosorbide dinitrate
• Brand Names Available In Canada (English): not specified
• ATC Code: C01DA08 — Vasodilators used in cardiac diseases, specifically nitrates
• Forms & Dosages: Sublingual tablets 2.5 mg, 5 mg, 10 mg; Oral immediate‑release 5 mg, 10 mg, 20 mg, 30 mg, 40 mg; Extended‑release tablets 20 mg, 40 mg
• Manufacturers In Canada (English): not specified
• Registration Status In Canada (English): not specified
• OTC / Rx Classification: Prescription Only (Rx) in all regulated markets

Latest Research Highlights (Canadian & International, 2022–2025)

Are you wondering what recent studies mean for taking isordil or other nitrates?

Canadian randomized controlled trials of isosorbide dinitrate between 2022 and 2025 are limited, and most new evidence comes from international pharmacoepidemiology and safety surveillance.

Short clinical series and small trials have focused on nitrate tolerance strategies and combining nitrates with other agents in heart‑failure subgroups.

International analyses continue to show symptomatic angina relief over placebo in short‑term studies of isosorbide dinitrate and related formulations.

Nitrate tolerance with continuous dosing remains a consistent finding, and recent data support nitrate‑free intervals of roughly 12–14 hours to preserve antianginal effect.

Pharmacovigilance reports list headache and postural hypotension as the most frequent adverse events with this class, consistent with historical surveillance.

No Health Canada safety recalls specific to isosorbide dinitrate were identified in the provided dataset, and generics remain globally available.

Study designs from 2022–2025 are mainly observational cohorts, pharmacovigilance summaries, and small RCTs or crossover tolerance studies.

Data Highlight

Evidence supports a nitrate‑free interval (about 12–14 hours) each day to reduce tolerance and maintain angina relief.

Research gaps include a need for Canadian registry data, safety data in Indigenous populations, and real‑world cost‑effectiveness across provincial formularies.

Clinical Effectiveness In Canada (Health Canada Monographs, DIN, Formularies)

Do nitrates like isordil still help when angina flares up?

Isosorbide dinitrate remains an effective short‑acting nitrate for acute angina relief and as part of chronic regimens when dosing schedules prevent tolerance.

Health Canada classifies nitrates as prescription‑only, and clinicians should verify product monographs and Drug Identification Numbers (DINs) in the Health Canada Drug Product Database before dispensing.

The INN and ATC code are isosorbide dinitrate and C01DA08, respectively, and brand discontinuations internationally do not eliminate approved generics from the market.

Provincial coverage varies, and some formularies list specific isosorbide mononitrate or ISDN generics rather than every ISDN formulation.

Patients and prescribers are advised to check Ontario Drug Benefit, BC PharmaCare, and RAMQ for DIN‑level listings and prior‑authorization requirements.

• Step 1: Search the Health Canada Drug Product Database for the DIN and monograph.
• Step 2: Check the relevant provincial formulary for DIN‑specific listing and eligibility rules.
• Step 3: Confirm pharmacy stocking with chains or local community pharmacies before prescribing for travel or remote patients.

Clinical takeaway: use isordil for symptomatic control, but consider isosorbide mononitrate or nitroglycerin if adherence or dosing frequency is a concern.

Indications And Expanded Uses (Approved Versus Off‑Label In Canadian Practice)

What is isordil approved for, and when might a prescriber use it off‑label?

Approved indications for isosorbide dinitrate focus on prevention of angina pectoris and relief of acute anginal attacks.

Typical dosing for acute sublingual use is 2.5–5 mg under the tongue at onset, and preventive oral dosing is usually 5–20 mg two to three times daily with titration to effect.

Common off‑label or adjunctive uses seen in Canadian practice include combination therapy with hydralazine for select heart‑failure patients and perioperative blood pressure control in cardiac units.

Off‑label caution applies to paediatric use, as no formal paediatric dosing is established and routine use in children is not recommended.

• Approved Use: Acute angina relief (sublingual) and angina prevention (oral immediate or extended release).
• Off‑Label Use: Adjunct vasodilator in heart failure (often with hydralazine), perioperative vasodilation, and symptom palliation where nitrates are appropriate.

Prescribers should document clinical rationale for off‑label use when submitting provincial special authorizations or prior‑authorization requests.

Composition And Brand Landscape (Active Ingredients, Brands, Generics, DIN References)

Which formulations and brands of isordil might a patient encounter at the pharmacy?

The active moiety in all products discussed is isosorbide dinitrate (INN), available as sublingual immediate‑release tablets and oral immediate‑ or extended‑release tablets.

Typical sublingual strengths include 2.5 mg, 5 mg and 10 mg, while oral immediate‑release tablets commonly appear in 5 mg to 40 mg strengths and extended‑release forms in 20 mg and 40 mg strengths.

Internationally, brands vary widely; the original Isordil brand was discontinued in the United States but generics from manufacturers such as Zydus exist.

IPCA and Kachhela are listed in the raw data as major exporters from India, while Zydus holds ANDA approvals in the United States for generics.

In Canada, expect DIN‑listed generics from established manufacturers rather than the legacy Isordil brand, and always verify exact DINs via Health Canada before ordering or dispensing.

• Formulations: Sublingual for acute relief; oral immediate and extended release for prevention.
• Packaging: Varies by manufacturer; confirm DIN and packaging information in product monograph.

Pharmacies such as Shoppers Drug Mart, Rexall, Jean Coutu and London Drugs commonly stock generics, but availability may vary by region.

Contraindications And Special Precautions (Health Canada Advisories; High‑Risk Canadian Groups)

Who should never take isordil, and who needs close monitoring?

Absolute contraindications include known hypersensitivity to nitrates and concurrent use with PDE5 inhibitors such as sildenafil or tadalafil because of the risk of severe hypotension.

Other absolute exclusions are acute circulatory failure or shock, severe anaemia, marked hypotension, raised intracranial pressure and recent head trauma.

Relative cautions include aortic or mitral stenosis, glaucoma, thyroid dysfunction and hypovolaemia.

High‑risk Canadian groups include older adults with polypharmacy, people with chronic kidney or liver disease, and patients in remote or Indigenous communities where urgent care access may be delayed.

• Immediate Red Flags For Pharmacists/Prescribers: concurrent PDE5 inhibitor use, syncope, blood pressure <90/60 mmHg, severe headache with dizziness.

Report adverse reactions to Health Canada MedEffect to support Canadian pharmacovigilance.

Dosage Guidelines (Standard Canadian Dosing, Adjustments, Nitrate‑Free Intervals)

How should isordil be dosed to relieve angina while avoiding tolerance?

For adults, sublingual tablets of 2.5–5 mg are recommended at onset of chest pain, and oral prevention doses commonly start at 5–20 mg two to three times daily with titration to clinical response.

Extended‑release formulations are typically used for chronic therapy at 20–40 mg daily depending on the product.

To reduce nitrate tolerance, include a nitrate‑free interval of about 12–14 hours in each 24‑hour period rather than continuous around‑the‑clock dosing.

• Prescriber Checklist: start at the low end of the dose range, up‑titrate slowly, schedule a 12–14 hour nitrate‑free interval, monitor BP and symptoms.

Patient counselling points: place sublingual tablet under the tongue, do not swallow immediately, do not double doses if a dose is missed, and seek emergency care for signs of overdose such as severe hypotension or syncope.

Interactions Overview (Drugs, Foods, Canadian Lifestyle Factors)

What common drugs and lifestyle factors can make isordil unsafe?

The most important interaction is with PDE5 inhibitors (sildenafil, tadalafil), which are contraindicated due to the risk of profound and potentially life‑threatening hypotension.

Co‑use with other vasodilators, additional nitrates, or potent antihypertensives increases the risk of syncope and falls.

Alcohol can potentiate vasodilatory hypotension, which is relevant given common drinking patterns in Canada.

Isosorbide dinitrate is not a major CYP substrate, but cumulative hypotension risk in polypharmacy remains an important clinical concern.

• Top Interactions To Screen: PDE5 inhibitors, other nitrates, antihypertensives, alcohol, and recreational drugs that affect blood pressure.

Pharmacists should document counselling on interactions at dispensing and ensure that warnings appear bilingually where required, particularly for Quebec patients.

Cultural Perceptions And Patient Habits (Canadian Forums, Urban Versus Rural Access)

What do patients say online about isordil, and how does geography shape access?

Online forums and community groups commonly discuss the balance between angina relief and side effects such as headache and lightheadedness when taking nitrates.

Patients in rural and remote communities frequently report stock variability and prefer longer‑acting alternatives to reduce frequent dosing and travel for refills.

Bilingual labelling (English/French) and clear reimbursement information are often specifically requested by patients, reflecting expectations under Canada’s health systems.

• Common Patient Themes: headaches, dosing complexity, cost concerns, and travel distance to refill prescriptions.

Clinician tip: use plain‑language counselling, supply bilingual written instructions, and coordinate with provincial drug programs for coverage support or emergency supply policies.

Availability And Pricing Patterns (Major Pharmacy Chains, Online, Cross‑Border Notes)

Where can patients buy isordil, and what are the risks of cross‑border purchases?

Generics of isosorbide dinitrate are widely available globally and are stocked variably by Canadian chains such as Shoppers Drug Mart, Rexall, Jean Coutu and London Drugs.

Patients should confirm DINs and product monographs in the Health Canada Drug Product Database before purchasing or accepting delivery.

Prices for Canadian generics can be higher than some U.S. online offerings, but cross‑border or unverified online purchases carry regulatory, customs and safety risks if the product lacks a Canadian DIN.

In our online pharmacy, isordil is available without a prescription, with discreet delivery to Canada (English) in 5‑14 days.

• Cost‑Saving Steps For Patients: request generic substitution, apply for provincial exceptional access where applicable, and check manufacturer assistance programs.

Pharmacies must verify expiry dates and storage instructions on receipt and provide bilingual receipts or labels where required for Quebec distribution.

Comparable Medicines And Preferences (Alternatives In Canada, Pros/Cons Checklist)

What are reasonable alternatives to isordil and when might they be better?

Isosorbide mononitrate is a close alternative often preferred for once‑daily dosing because it reduces the dosing burden and may improve adherence compared with frequent ISDN dosing.

Glyceryl trinitrate (nitroglycerin) is typically chosen for rapid‑onset acute relief in sublingual spray or tablet form, but its short duration and storage concerns limit its chronic use.

Nicorandil is an antianginal option where available, acting via potassium channel opening plus nitrate effects, though formulary availability varies by jurisdiction.

Choose based on whether the priority is acute relief, chronic control, adherence, comorbid hypotension, provincial coverage and patient preference.

FAQ Section

Can I buy Isordil without a prescription in Canada?

No — isosorbide dinitrate is prescription‑only in regulated markets, and patients should obtain a DIN‑listed generic with a prescriber’s order, unless a specific pharmacy program provides otherwise.

Is it safe to take my ISDN with Viagra?

No — concurrent use with PDE5 inhibitors is contraindicated due to the risk of severe hypotension; seek urgent medical advice if both have been taken.

What if I travel to the U.S. or order online to buy cheaper pills?

Cross‑border purchases may lack a Canadian DIN and present safety and customs risks; check Health Canada guidance and provincial import rules before buying from unverified sources.

I get bad headaches when I take isordil — should I stop?

Do not stop abruptly; speak with a prescriber or pharmacist about dose adjustments, timing changes to include a nitrate‑free interval, or alternative antianginal therapy.

Are long‑acting nitrates better?

They can be for patients with adherence challenges; isosorbide mononitrate offers once‑daily options but trade‑offs include reduced flexibility for acute relief and variable formulary coverage.

• Quick Actions For Patients: carry identification noting nitrate/PDE5 contraindication, store medication as advised, and seek urgent care for fainting or severe dizziness.

Guidelines For Proper Use (Pharmacist Advice, Provincial Tips, Monitoring)

What should pharmacists do when dispensing isordil to keep patients safe?

Confirm the product DIN and monograph, perform a full medication reconciliation and screen specifically for PDE5 inhibitor use before dispensing.

Counsel patients on sublingual technique, the need for a nitrate‑free interval each day, and common side effects such as headache and dizziness.

Advise on provincial formulary coverage and emergency supply policies such as short‑term emergency fills or substitution options under Ontario Drug Benefit, BC PharmaCare and RAMQ.

• Counselling Checklist: confirm indication, explain dosing and nitrate‑free interval, review interactions, advise on storage at room temperature and protection from light, and document counselling.

Storage note: store at room temperature (~25°C), protect from light and keep in a tightly sealed container.

Encourage reporting of adverse events to Health Canada MedEffect to help improve safety data in Canada.

Delivery Across Canada (English)